Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2).
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu LM, Tomei G, Pollard R, Vincent SA, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckley C, Coles A.
Lennox B, et al. Among authors: joyce e.
Trials. 2019 Jun 7;20(1):331. doi: 10.1186/s13063-019-3336-1.
Trials. 2019.
PMID: 31174586
Free PMC article.